JUNE 28 - JULY 2, 2020  
30 years of Care Transitions Across the Full Continuum

PP203 – Using Patient Activation to Improve Outcomes

PP203 – Using Patient Activation to Improve Outcomes

Patient engagement is becoming an important area of focus as healthcare organization migrate to value-based care (VBC). Having the ability to risk stratify our patients by medical risk coupled with engagement risk allows us to fully understand our patient total active risk.  Research has shown that using advanced techniques to identify patients at their lowest level of health self-management and highest risk, while initiating early interventions, leads to reductions in healthcare utilization cost and improved health outcomes.

IHA’s goal was to find an evidenced-based tool to identify the activation levels of our patients so that we could manage our population more effectively and develop more relevant care plans.  We chose an evidence-based survey mechanism created by Insignia Health called Patient Activation Measure (PAM).  The patient’s response to this 10 statement survey generates a score that is converted to an activation level ranging from 1 to 4, with 1 being the least activated.

All patients identified in our care management services completes a PAM survey.  We then use their activation level to guide us in providing disease specific education, coupled with motivational interviewing techniques and patient centered realistic goal setting to tailor their learning experience and meet them where they are in their health care journey.  So far, results from our year-long program have shown a significant 12 point improvement in PAM scores for our least activated patients.  A 3-point change is considered clinically significant.  In addition, we are seeing improvements in our clinical measures.

The anticipated benefits to patient management include the ability to better risk stratify our patients using not only medical risk but engagement risk was well. Having these risk measures will allow our care managers and other providers to have a better understanding of a patient’s total active risk while assisting their level of activation.